Sorry, another one and i do feel like i am getting a little obsessive on the issue but why don't the incumbent tavr providers need to get FDA approval for ViV? If they don't need it, surely approval for Duravr is also sufficient for this market.
AVR Price at posting:
$19.61 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)